Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday? - Cullinan Therapeutics (NASDAQ:CGEM)

Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus erythematosus.

Related Keywords

United States ,American ,William Blair ,Society Of Clinical Oncology ,Cullinan Therapeutics Inc ,Amgen Inc ,Cullinan Therapeutics ,Cullinan Oncology ,